Pfizer

News

Equity_World_Access_Map_1140x675_CountryList

Pfizer makes non-profit pledge for low-income nations

US pharma giant Pfizer has said it will sell some of its patented medicines at non-profit prices to 45 of the world's poorest countries – including new launches.

News

Open communication helps ulcerative colitis patients through COVID-19

Pfizer's Arena buyout looks canny, as etrasimod aces phase 3...

Pfizer placed a $6.7 billion bet on the outcome of two phase 3 trials of Arena Pharmaceu

News

Sidekick and Pfizer prep launch of DTx for atopic dermatitis

A long-running partnership between digital therapeutics (DTx) developer Si

Digital

Pfizer: Pharma needs a business strategy for a digital world

The unprecedented rate of digital acceleration seen in the first two years of COVID-19 has set in train an age of digital transformation.

News

Pfizer upgrades Biohaven alliance to a takeover bid

Not content with a $1.2 billion licensing deal for Biohaven Pharma's oral migrain

News

Doctor in white rubber protective gloves putting adhesive bandage on young man's arm after scratch on skin or injection of vaccine. First aid. Medical, pharmacy and healthcare concept. Closeup.

COV-BOOST trial data show value of fourth dose

Administering a fourth dose of an mRNA COVID-19 vaccine provides a stronger level of protection than a third dose, particularly in the over-70s, according to the latest readout from the UK

Pfizer makes non-profit pledge for low-income nations

Pfizer's Arena buyout looks canny, as etrasimod aces phase 3...

Sidekick and Pfizer prep launch of DTx for atopic dermatitis

Pfizer: Pharma needs a business strategy for a digital world

Pfizer upgrades Biohaven alliance to a takeover bid

COV-BOOST trial data show value of fourth dose

Getting predictive technologies to patients, with Concr

Discover a new era of healthcare panel engagement: Grounded ...

Pfizer

Editor's Picks